Pharma IP Summit: China’s patent linkage system losing steam
A lack of policy direction and timeline on patent linkage is creating industry doubts, but some believe that China shouldn’t rush it forward
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: